Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Contineum Therapeutics, Inc.

Contineum Therapeutics to Attend Upcoming Investor Conferences
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics to Present at Multiple Upcoming Investor Conferences
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
From Contineum Therapeutics, Inc.
Via Business Wire
Tickers CTNM
Contineum Therapeutics Announces Pricing of Initial Public Offering
From Contineum Therapeutics, Inc.
Via GlobeNewswire
Pipeline Therapeutics Changes Name to Contineum Therapeutics to Reflect Expanded Focus on NI&I Therapeutic Indications (Neuroscience, Inflammation and Immunology)
From Contineum Therapeutics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS